Literature DB >> 61974

Changes in protease inhibitors after acute myocardial infarction.

J A Rennie, G P Crawford, D Ogston.   

Abstract

Plasma levels of fibrinogen, alpha1-antitrypsin, alpha2-macroglobulin, antithrombin III, and C1 inactivator were measured serially for 10 days in 11 patients after acute myocardial infarction. Both fibrinogen and alpha1-antitrypsin rose markedly to reach peak levels 5-7 days after infarction while C1 inactivator levels rose slowly with the highest observed mean level on the 10th postinfarction day. Neither antithrombin III nor alpha2-macroglobulin changed significantly after myocardial infarction. No relationship between C1 inactivator levels and either fibrinogen or alpha1-antitrypsin was found in a study of 30 patients with a variety of disorders while fibrinogen and alpha1-antitrypsin levels were significantly correlated.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 61974      PMCID： PMC476132          DOI： 10.1136/jcp.29.7.639

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  15 in total

1.  Acute phase reactants. I. Serum nonglucosamine polysaccharides in patients with rheumatic fever and related conditions.

Authors:  V C KELLEY
Journal:  J Pediatr       Date:  1952-04       Impact factor: 4.406

2.  Studies on the blood fibrinolytic enzyme system following acute myocardial infarction.

Authors:  N B Bennett; C M Ogston; D Ogston
Journal:  Clin Sci       Date:  1967-02       Impact factor: 6.124

3.  The plasmin inhibitor of human plasma. IV. Its action on plasmin, trypsin, chymotrypsin, and thrombin.

Authors:  A Rimon; Y Shamash; B Shapiro
Journal:  J Biol Chem       Date:  1966-11-10       Impact factor: 5.157

4.  Serum inhibition of plasmin and of plasminogen activation in thrombotic diseases.

Authors:  G Tsitouris; R Stathopoulou; I Tsevrenis
Journal:  J Atheroscler Res       Date:  1967 Jul-Aug

5.  The inhibition of human plasmin by human antithrombin-heparin cofactor.

Authors:  R F Highsmith; R D Rosenberg
Journal:  J Biol Chem       Date:  1974-07-25       Impact factor: 5.157

6.  Serum zinc and alpha2-macroglobulin concentration in myocardial infarction, decubitus ulcer, multiple myeloma, prostatic carcinoma, Down's syndrome and nephrotic syndrome.

Authors:  L D McBean; J C Smith; B H Berne; J A Halsted
Journal:  Clin Chim Acta       Date:  1974-01-19       Impact factor: 3.786

7.  125-I-labelled fibrinogen test adapted for routine screening for deep-vein thrombosis.

Authors:  V V Kakkar; A N Nicolaides; J T Renney; J R Friend; M B Clarke
Journal:  Lancet       Date:  1970-03-14       Impact factor: 79.321

8.  Fibrinogen concentration in acute myocardial infarction; comparison of the clot density determination of fibrinogen with the erythrocyte sedimentation rate.

Authors:  S LOSNER; B W VOLK; N D WILENSKY
Journal:  AMA Arch Intern Med       Date:  1954-02

9.  Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease.

Authors:  C M Ogston; D Ogston
Journal:  J Clin Pathol       Date:  1966-07       Impact factor: 3.411

10.  The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor.

Authors:  O D Ratnoff; J Pensky; D Ogston; G B Naff
Journal:  J Exp Med       Date:  1969-02-01       Impact factor: 14.307
View more
  3 in total

1.  Systems analysis of gene ontology and biological pathways involved in post-myocardial infarction responses.

Authors:  Nguyen T Nguyen; Merry L Lindsey; Yu-Fang Jin
Journal:  BMC Genomics       Date:  2015-06-11       Impact factor: 3.969

2.  [Stress-metabolism after myocardial infarction-demonstrated by means of the behaviour of plasma proteins with short half-life (author's transl)].

Authors:  G Ollenschläger; H Gofferje; L Horbach; H Prestele; K Schultis
Journal:  Klin Wochenschr       Date:  1981-05-04

3.  Alpha 1-antitrypsin in acute myocardial infarction.

Authors:  H Gilutz; Y Siegel; E Paran; N Cristal; M R Quastel
Journal:  Br Heart J       Date:  1983-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.